journal article·2015-10-27Open access

Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics

Peng Huang, Yuan Gao, Jing Lin, Hao Hu, Hsien-Shun Liao, Xuefeng Yan, Yuxia Tang, Albert Jin, Jibin Song, Gang Niu, Guofeng Zhang, Ferenc Horkay, Xiaoyuan Chen

ACS Nano· Volume 9· Issue 10

Abstract

Despite the effort of developing various nanodelivery systems, most of them suffer from undesired high uptakes by the reticuloendothelial system, such as liver and spleen. Herein we develop an endogenous phosphatase-triggered coassembly strategy to form tumor-specific indocyanine green (ICG)-doped nanofibers (5) for cancer theranostics. Based on coordinated intermolecular interactions, 5 significantly altered near-infrared absorbance of ICG, which improves the critical photoacoustic and photothermal properties. The phosphatase-instructed coassembly process, as well as its theranostic capability, was successfully conducted at different levels ranging from in vitro, living cell, tissue mimic, to in vivo. Specifically, the tumor uptake of ICG was markedly increased to 15.05 ± 3.78%ID/g, which was 25-fold higher than that of free ICG (0.59 ± 0.24%ID/g) at 4 h after intravenous injection. The resulting ultrahigh T/N ratios (>15) clearly differentiated tumors from the surrounding normal tissue. Complete tumor elimination with high therapeutic accuracy has been successfully achieved upon laser irradiation (0.8 W/cm(2), 5 min) within 24-48 h postinjection. As the first example, in vivo formation of tumor-specific ICG-doped nanofiber for PTT theranostics owns the immense potential for clinical translation of personalized nanomedicine with targeted drug delivery as well as for cancer theranostics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, Bethesda, Maryland 20892, United States

Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, Department of Biomedical Engineering, School of Medicine, Shenzhen University, Shenzhen 518060, China

Section on Tissue Biophysics and Biomimetics, Program on Pediatric Imaging and Tissue Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, United States

Beijing Engineering Research Center for BioNanotechnology and CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11 Zhongguancun Beiyitiao, Beijing 100190, China

Laboratory of Cellular Imaging and Macromolecular Biophysics, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, Bethesda, Maryland 20892, United States

Funding

U.S. Department of Health and Human Services · National Natural Science Foundation of China · U.S. Department of Commerce

References (40)

Show source-provided references
1. 10.3322/caac.2119910.3322/caac.21199 ↗
2. 10.1038/nmat298610.1038/nmat2986 ↗
3. 10.1021/ja057254a10.1021/ja057254a ↗
4. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
5. 10.1021/ja503115n10.1021/ja503115n ↗
6. 10.1073/pnas.223247910010.1073/pnas.2232479100 ↗
7. 10.1002/adma.20140091410.1002/adma.201400914 ↗
8. 10.1126/scitranslmed.300157710.1126/scitranslmed.3001577 ↗
9. 10.1038/srep0218010.1038/srep02180 ↗
10. 10.1016/S0039-6257(00)00123-510.1016/S0039-6257(00)00123-5 ↗
11. 10.1117/1.JBO.19.9.09600210.1117/1.JBO.19.9.096002 ↗
12. 10.1021/nn506238610.1021/nn5062386 ↗
13. 10.2217/nnm.14.11810.2217/nnm.14.118 ↗
14. 10.1016/j.biomaterials.2014.04.01910.1016/j.biomaterials.2014.04.019 ↗
15. 10.1021/am500439310.1021/am5004393 ↗
16. 10.1016/j.biomaterials.2013.08.02210.1016/j.biomaterials.2013.08.022 ↗
17. 10.1038/nnano.2015.2510.1038/nnano.2015.25 ↗
18. 10.1039/b919450a10.1039/b919450a ↗
19. 10.1021/ar700191410.1021/ar7001914 ↗
20. 10.1002/bip.2132810.1002/bip.21328 ↗
21. 10.1021/nl802813f10.1021/nl802813f ↗
22. 10.1002/anie.20035245810.1002/anie.200352458 ↗
23. 10.1021/ja902825j10.1021/ja902825j ↗
24. 10.1039/c2cc33631f10.1039/c2cc33631f ↗
25. 10.1002/anie.20110861210.1002/anie.201108612 ↗
26. 10.1021/bm401319c10.1021/bm401319c ↗
27. 10.1038/nmat225010.1038/nmat2250 ↗
28. 10.1021/ja904411z10.1021/ja904411z ↗
29. 10.1021/ja404215g10.1021/ja404215g ↗
30. 10.1021/ja311598310.1021/ja3115983 ↗
31. 10.1021/nn401667z10.1021/nn401667z ↗
32. 10.1038/ncomms204010.1038/ncomms2040 ↗
33. 10.1038/nchem.48010.1038/nchem.480 ↗
34. 10.1158/0008-5472.CAN-06-433810.1158/0008-5472.CAN-06-4338 ↗
35. 10.1021/nn403664n10.1021/nn403664n ↗
36. 10.1021/cr400532z10.1021/cr400532z ↗
37. 10.1002/anie.20130898610.1002/anie.201308986 ↗
38. 10.1002/adma.20130189010.1002/adma.201301890 ↗
39. 10.1002/anie.20100230710.1002/anie.201002307 ↗
40. 10.1021/ja053314110.1021/ja0533141 ↗